How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Forbes contributors publish independent expert analyses and insights. I write about the business of healthcare. This article is more than 4 years old. Chris Gibson, Co-Founder & CEO, Recursion ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of Wednesday’s worst performers. Recursion Pharmaceuticals dropped for a third straight day on Wednesday, slashing 6.29 percent to close at $4.77 ...

One person that helped bring the chill was an analyst cutting his price target. Another two were executives at the biotech selling chunks of stock. The company was the target of an analyst price ...

RXRX has upcoming data in H2'25 from the TUPELO trial of REC-4881 in familial adenomatous polyposis. The company will also report data from the ELUCIDATE trial of REC-617 in H2'25. A previous update ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Lior Ron, the entrepreneur who founded and ran Uber Technologies Inc.’s freight and logistics unit, is returning to the world of self-driving big rigs. Ron is joining autonomous trucking and AI ...

Head coach Kyle Shanahan announced the 2025 team captains, provided updates on player injuries, and shared insights on the 49ers preparations for their Week 1 matchup against the Seattle Seahawks. WON ...

Cracker Barrel's $700 million rebranding effort is joining a list of corporate missteps that have sparked public backlash. The public outcry is centered on Cracker Barrel's new logo, which includes a ...

The halt by one of the world’s largest couriers comes after President Trump eliminated an exemption on tariffs levied on imported goods valued under $800. By Christopher F. Schuetze Reporting from ...